active treatment rather than a negative lack of treatment or, as Professor Stjernsward puts it, 'a waste-paper basket alternative' runs throughout the text and unifies the whole. The holistic and interdisciplinary nature of palliative care is emphasised by comprehensive and well-written chapters on ethical, cultural and spiritual issues and bereavement. The section on rehabilitation is noteworthy in that it covers topics as diverse as stoma management and music therapy as well as incontrovertibly demonstrating that rehabilitation is an intrinsic part of palliative medicine.
The importance of research in palliative care is a recurring theme throughout the book, and a specific section is devoted to this topic. Studies in this field are, however, relatively sparse, and the reasons for this are acknowledged and duly addressed. In particular, Calman and Hanks refer to the widespread view that 'scientifically rigorous clinical research is incompatible with the basic tenets of palliative care', and they put forward cogent arguments to refute this. This section of the book is extremely wide-ranging, and discussion is not limited to research into pharmacological and nonpharmacological symptom management as nursing, psychological and social issues are also well covered. The fact that palliative care crosses the traditional barriers of discipline and specialty is highlighted in the section on education and training. The authors stress that all the members of any hospital-based or domiciliary team caring for patients with cancer, be they doctors, nurses, social workers, physiotherapists or clergy, need at least a working knowledge of the philosophy of palliative care and suggest that this subject should become an integral part of the curriculum of all student health care professionals.
Although multiauthorship can bring problems through inevitable variability of both style and approach, these are not very apparent and there is a uniformly high standard of presentation throughout the book. Despite a degree of overlap between chapters there is surprisingly little repetition. The textbook is well indexed and all of the chapters are more than adequately referenced. In parts, the text is rather dry and it is tempting to speculate that it could be lightened by more case histories and illustrations.
The book concludes with a thought-provoking dissertation on the global perpsective of palliative medicine. Each year fifty million people die worldwide. At least 10% die of malignant disease, and it is likely that this proportion, in addition to the numbers dying from AIDS-related diseases, will continue to increase. Given that even in resource-rich, developed nations there is inadequate application of the available knowledge on palliative care, it is perhaps not surprising that globally this field of medicine is badly neglected. To rectify this situation changes are necessary not only in medical practice but also in political, socioeconomic, social and ethical arenas. The World Health Organization has designated palliative care a priority in its Global Cancer Control Programme, and encouraging progress is already being achieved.
The Oxford Textbook of Palliative Medicine is a book both to dip in to, at leisure and when faced with an urgent clinical problem to solve, and to read systematically to gain a full insight into this field. Whilst its publication undoubtedly represents a coming of age of palliative medicine as a specialty in its own right, it is equally obvious that this new specialty must continue to evolve. This book sets out to put forward the rationale for and history to date of integrating chemotherapy and radiation in the management of cancer. The book is divided into five sections, with a brief introduction, the biological principles underlining combined modality therapy, a clinical section covering 17 disease sites, a section on toxicity and an appendix summarising current clinical trials addressing the issue. The second section includes some basic information about the mechanisms and action of both radiation and cytotoxic drugs, but most attention is focused on their use as sole modalities with little information about possible interactions. The clinical chapters are comprehensive and give an excellent overview of combined modality therapy in the individual disease sites. The section on toxicity tends to reproduce some of the information included in the clinical chapters. Overall, this book may be useful as a reference source in a departmental library but it is unlikely to be of everyday relevance to the majority of oncology clinicians. The review on sequence-and gene-specific drugs by D'Incalci, Broggini and Hartley concentrates on alkylating agents and their reactions with DNA as the major biochemical events underpinning their cytotoxicities. It has been known for some time that DNA damage is attributable to singleand double-strand breaks, inter-and intra-strand cross-links and possibly to DNA-protein cross-links. The site most frequently alkylated is guanine N7, with lesser reaction occurring at guanine 06 and adenine N3. The authors review methodology which now enables an understanding of how DNA base sequences influence the sites of alkylation of various clinically used alkylating agents. It is now clear that many common bifunctional alkylating agents react preferentially with guanine N7 in contiguous runs of guanines in the major groove of DNA. The authors emphasise that these studies are carried out with parent drug and purified DNA and take no account of cellular metabolism. Minor groove binders include mitomycin C and CC-1065.
Claude Helene discussed antisense and antigene oligonucleotides and synthetic ribozymes. The major requirements of antisense oligos are emphasised: nuclease stability; preservation of RNAse H activity; good cell penetration. The advantages and shortcomings of the various linker chemistries and the properties of chimaeric molecules comprising conventional phosphodiester linkers in association with methyl phosphonate, phosphorothioate or phosphoramidate units is reviewed. Other chemical manoeuvres, including coupling of oligos to hydrophobic moieties to enhance transport and attachment of alkylating residues, both to achieve nuclease stability and to increase potency, are mentioned also. A consistent theme is the high selectivity that can be achieved with antisense oligonucleotides in their effects, for example on parasitically or virally infected cells, as well as on tumour cells carrying a single point mutation in the Ha-ras oncogene, amplified c-myc or in CML cells, where the bcr-abl translocation can be targeted. Oligonucleotidedirected triple helix formation, where Hoogstein hydrogen bonding permits the association of a third oligo strand with the nuclear DNA, is described as an 'anti-gene' strategy. The triple helix can be effectively stabilised by the attachment of a 'docking' intercalator molecule. It is envisaged that this approach will interfere with the function of transcription factors and restriction enzymes, thus disturbing differentiation and cell division. The author concludes that the
